MedTech News
.................... by Andrew Celentano
FDA clears C2N Diagnostics’ early Alzheimer’s assessment test
C2N’s Alzheimer’s test is the first to be FDA-cleared for use in patients as young as 40 who present with cognitive impairment symptoms.
FDA authorizes first-of-its-kind autonomous robotic blood draw device
The FDA granted de novo classification to a standalone robotic device that can draw blood from a patient’s arm without a hands-on operator.
Implantica receives FDA approval for RefluxStop® – Opening the U.S. market
VADUZ, Liechtenstein, Aug. 21, 2026 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announced today that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for RefluxStop®, the company’s implant-based treatment for gastroesophageal reflux disease (GERD). The approval allows Implantica to begin commercial launch activities in the United States, the world’s largest medical device market.
AI-calculated brain age predicts dementia risk years before doctors can see it
Memory clinics still rely on visual rating scales to assess brain atrophy, yet these tools lack the sensitivity to catch subtle changes associated with early dementia. A measure of how old a person’s brain appears on brain scans compared with their actual age might be a potential predictor of who is more likely to develop dementia over the years, reports a new study published in Neurology.
New guide could help scientists see deeper into the human body using light and sound
Scientists have published the most comprehensive analysis to date of ultrasound detectors underpinning photoacoustic tomography (PAT)—a fast-emerging medical imaging technology capable of revealing blood vessels, tumors and tissue function deep inside the body.
Prostate cancer hijacks amino acid metabolism to signal hormone therapy resistance
Prostate tumors can rewire amino acid metabolism to override the normal brakes on cholesterol production, a process that may fuel hormone therapy resistance, according to a study by Weill Cornell Medicine investigators.
A single application of anti-mosquito coating reduces the long-term risk of dengue
A single application to water containers can significantly reduce yellow fever mosquito (Aedes aegypti) populations—and thus the spread of dengue fever—for many months. Researchers from the Faculty of Medicine at the University of Freiburg demonstrated this in a study published in The Lancet Infectious Diseases.
AI-guided screening identifies nine drugs that may slow childhood dementia
An Australian research collaboration has identified several existing TGA-approved medicines that could help slow brain damage in children with a rare form of dementia—offering hope for faster treatment options.